 VANCOUVER, Wash., Sept. 07, 2021 GLOBE NEWSWIRE -- Absci Corporation Nasdaq: ABSI, the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter ended June 30, 2021. 